FAS and metabolic dysfunction-associated steatohepatitis: Patients with NASH show an increase in hepatic NK cells and significantly higher expression levels of NKG2D, MIC A/B, TRAIL-DR5, and CD95/Fas in liver tissues than those of healthy controls [74].